NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 12 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,974,463 | +0.0% | 37,749,000 | 0.0% | 0.36% | -2.2% |
| Q2 2023 | $34,968,892 | +14.4% | 37,749,000 | +14.7% | 0.37% | +14.0% |
| Q1 2023 | $30,579,098 | +159.8% | 32,899,000 | +136.7% | 0.32% | +159.7% |
| Q4 2022 | $11,770,638 | +14.8% | 13,899,000 | +15.2% | 0.12% | +31.9% |
| Q3 2022 | $10,256,000 | +1.3% | 12,066,000 | 0.0% | 0.09% | +1.1% |
| Q2 2022 | $10,120,000 | -2.3% | 12,066,000 | 0.0% | 0.09% | +43.1% |
| Q1 2022 | $10,358,000 | +91.1% | 12,066,000 | +164.3% | 0.06% | +97.0% |
| Q4 2021 | $5,420,000 | -19.8% | 4,566,000 | 0.0% | 0.03% | -17.5% |
| Q3 2021 | $6,758,000 | +4.0% | 4,566,000 | 0.0% | 0.04% | +17.6% |
| Q2 2021 | $6,497,000 | +43.9% | 4,566,000 | +52.2% | 0.03% | +3.0% |
| Q1 2021 | $4,514,000 | -7.2% | 3,000,000 | 0.0% | 0.03% | -8.3% |
| Q4 2020 | $4,865,000 | +30.3% | 3,000,000 | 0.0% | 0.04% | -20.0% |
| Q3 2020 | $3,733,000 | +73.1% | 3,000,000 | +50.0% | 0.04% | +28.6% |
| Q2 2020 | $2,157,000 | – | 2,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 15,750,000 | $13,592,000 | 1.09% |
| Context Capital Management, LLC | 13,000 | $11,214,000 | 0.73% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 19,422,000 | $16,659,000 | 0.27% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,386,000 | $15,685,000 | 0.15% |
| Aequim Alternative Investments LP | 3,500,000 | $3,019,000 | 0.08% |
| LINDEN ADVISORS LP | 12,066,000 | $10,358,000 | 0.06% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 23,500,000 | $20,269,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,000,000 | $12,937,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 16,900,000 | $14,517,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 10,323,000 | $8,800,358,000 | 0.01% |